Diabetic patients treated with dialysis: Complications and quality of life

Diabetologia

Volumn 50, Issue 11, 2007, Pages 2254-2262

  Sorensen V R ^a   Mathiesen, E R ^a   Watt, T ^a   Bjorner, J B ^b   Andersen, M V N ^a   Feldt Rasmussen, B ^a  

^a Mental Health Center Glostrup   (Denmark)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

Diabetes; Diabetic complications; Dialysis; End stage renal disease; KDQOL; Locus of Control; Maculopathy; Quality of life; Retinopathy; SF 36

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

AGED; ATTITUDE TO HEALTH; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; EMOTIONS; FEMALE; HEALTH STATUS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MENTAL HEALTH; MIDDLE AGED; PERITONEAL DIALYSIS; QUALITY OF LIFE; REFERENCE VALUES; RENAL DIALYSIS; SOCIAL BEHAVIOR;

EID: 34848812365     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0810-1     Document Type: Article

References (48)

1. Sorensen VR, Hansen PM, Heaf J, Feldt-Rasmussen B (2006) Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark. Kidney Int 70:187-191
2. Feldt-Rasmussen B (2006) Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Kidney Int 70:1392-1394
3. Kalantar-Zadeh K, Kopple JD, Regidor DL et al (2007) A1C and survival in maintenance hemodialysis patients. Diabetes Care 30:1049-1055
4. Sorensen VR, Mathiesen ER, Heaf J, Feldt-Rasmussen B (2007) Improved survival rate in patients with diabetes and end-stage renal disease in Denmark. Diabetologia 50(5):922-929
5. Wanner C, Krane V, Marz W et al (2004) Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res 27:259-266
6. Rajagopalan S, Dellegrottaglie S, Furniss AL et al (2006) Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114:1914-1922
7. Adler AI, Stratton IM, Neil HA et al (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412-419
8. Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
9. Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617-622
10. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393
11. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-878
12. Rossing K, Jacobsen P, Pietraszek L, Parving HH (2003) Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial. Diabetes Care 26:2268-2274
13. Chapman RH, Benner JS, Petrilla AA et al (2005) Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 165:1147-1152
14. Lerman I (2005) Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res 36:300-306
15. Rubin RR (2005) Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 118:27S-34S
16. Fagerudd J, Forsblom C, Pettersson-Fernholm K, Groop PH (2004) Implementation of guidelines for the prevention of diabetic nephropathy. Diabetes Care 27:803-804
17. Chao J, Nau DP, Aikens JE, Taylor SD (2005) The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Soc Adm Pharm 1:508-525
18. Schachinger H, Hegar K, Hermanns N et al (2005) Randomized controlled clinical trial of Blood Glucose Awareness Training (BGAT III) in Switzerland and Germany. J Behav Med 28:587-594
19. Reynaert C, Janne P, Donckier J et al (1995) Locus of control and metabolic control. Diabete Metab 21:180-187
20. O'Hea EL, Grothe KB, Bodenlos JS, Boudreaux ED, White MA, Brantley PJ (2005) Predicting medical regimen adherence: the interactions of health locus of control beliefs. J Health Psychol 10:705-717
21. Tillotson LM, Smith MS (1996) Locus of control, social support, and adherence to the diabetes regimen. Diabetes Educ 22:133-139
22. Schlenk EA, Hart LK (1984) Relationship between health locus of control, health value, and social support and compliance of persons with diabetes mellitus. Diabetes Care 7:566-574
23. Wallston KA (2005) The validity of the multidimensional health locus of control scales. J Health Psychol 10:623-631
24. Danish National Institute of Public Health (2006) The national health and morbidity survey 2005. Danish National Institute of Public Health, Copenhagen
25. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB (1994) Development of the Kidney Disease Quality of Life (KDQOL) instrument. Qual Life Res 3:329-338
26. Gorodetskaya I, Zenios S, McCulloch CE et al (2005) Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68:2801-2808
27. Fukuhara S, Lopes AA, Bragg-Gresham JL et al (2003) Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 64:1903-1910
28. Mapes DL, Lopes AA, Satayathum S et al (2003) Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 64:339-349
29. Valdes C, Garcia-Mendoza M, Rebollo P, Ortega T, Ortega F (2006) Mental health at the third month of haemodialysis as a predictor of short-term survival. Nephrol Dial Transplant 21:3223-3230
30. Bjorner JB, Damsgaard MT, Watt T, Groenvold M (1998) Tests of data quality, scaling assumptions, and reliability of the Danish SF-36. J Clin Epidemiol 51:1001-1011
31. Bjorner JB, Thunedborg K, Kristensen TS, Modvig J, Bech P (1998) The Danish SF-36 Health Survey: translation and preliminary validity studies. J Clin Epidemiol 51:991-999
32. Bro S, Bjorner JB, Tofte-Jensen P et al (1999) A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int 19:526-533
33. Molsted S, Heaf J, Prescott L, Eidemak I (2005) Reliability testing of the Danish version of the Kidney Disease Quality of Life Short Form. Scand J Urol Nephrol 39:498-502
34. Ware JE, Kosinski M (2001) Interpreting SF-36 summary health measures: a response. Qual Life Res 10:405-413
35. Bjorner JB, Damsgaard MT, Watt T et al (1997) Danish manual for the SF-36. Danish National Institute of Health, Copenhagen (in Danish)
36. Christensen AJ, Turner CW, Smith TW, Holman JM, Jr, Gregory MC (1991) Health locus of control and depression in end-stage renal disease. J Consult Clin Psychol 59:419-424
37. Game FL, Chipchase SY, Hubbard R, Burden RP, Jeffcoate WJ (2006) Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus. Nephrol Dial Transplant 21:3207-3210
38. Koch M, Trapp R, Kulas W, Grabensee B (2004) Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study. Nephrol Dial Transplant 19:2547-2552
39. Yasuhara H, Naka S, Yanagie H, Nagawa H (2002) Influence of diabetes on persistent nonhealing ischemic foot ulcer in end-stage renal disease. World J Surg 26:1360-1364
40. Locking-Cusolito H, Harwood L, Wilson B et al (2005) Prevalence of risk factors predisposing to foot problems in patients on hemodialysis. Nephrol Nurs J 32:373-384
41. Rith-Najarian S, Gohdes D (2000) Preventing amputations among patients with diabetes on dialysis. Diabetes Care 23:1445-1446
42. Cusick M, Chew EY, Hoogwerf B et al (2004) Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26. Kidney Int 66:1173-1179
43. Parving HH, Mogensen CE, Thomas MC, Brenner BM, Cooper ME (2005) Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study. QJM 98:119-126
44. Painter P, Carlson L, Carey S, Paul SM, Myll J (2000) Low-functioning hemodialysis patients improve with exercise training. Am J Kidney Dis 36:600-608
45. Molsted S, Eidemak I, Sorensen HT, Kristensen JH (2004) Five months of physical exercise in hemodialysis patients: effects on aerobic capacity, physical function and self-rated health. Nephron Clin Pract 96:c76-c81
46. Painter P, Carlson L, Carey S, Paul SM, Myll J (2000) Physical functioning and health-related quality-of-life changes with exercise training in hemodialysis patients. Am J Kidney Dis 35:482-492
47. Martinez-Castelao A, Gorriz JL, Garcia-Lopez F, Lopez-Revuelta K, De AF, Cruzado JM (2004) Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study). J Nephrol 17:544-551
48. Christensen K, Herskind AM, Vaupel JW (2006) Why Danes are smug: comparative study of life satisfaction in the European Union. BMJ 333:1289-1291